Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A(2) inhibitors.

[1]  P Bernard,et al.  Computer-aided molecular selection and design of natural bioactive molecules. , 1999, Current opinion in drug discovery & development.

[2]  R. Irvine.  How is the level of free arachidonic acid controlled in mammalian cells? , 1982, The Biochemical journal.

[3]  M. Pintore,et al.  Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2. , 2001, European journal of medicinal chemistry.

[4]  M. Sundaralingam,et al.  Structure of the complex of bovine pancreatic phospholipase A2 with a transition-state analogue. , 1998, Acta crystallographica. Section D, Biological crystallography.

[5]  Katsutoshi Yamada,et al.  Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'. , 2001, Bioorganic & medicinal chemistry letters.

[6]  K. H. Kalk,et al.  Role of the N-terminus in the interaction of pancreatic phospholipase A2 with aggregated substrates. Properties and crystal structure of transaminated phospholipase A2. , 1983, Biochemistry.

[7]  H. Friess,et al.  Phospholipase A2 Isoforms in Acute Pancreatitis , 2001, Annals of surgery.

[8]  Katsutoshi Yamada,et al.  Pyrrolidine inhibitors of human cytosolic phospholipase A(2). , 2000, Journal of medicinal chemistry.

[9]  M. Pintore,et al.  A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A2. , 2001, European journal of medicinal chemistry.

[10]  M. Lehr.  Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2. , 1997, Journal of medicinal chemistry.

[11]  J.-P. Wery,et al.  Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2 , 1995, Nature Structural Biology.

[12]  M. Recio,et al.  Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. , 1995, Planta medica.

[13]  J. D. Clark,et al.  Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Hol,et al.  Structure of bovine pancreatic phospholipase A2 at 1.7A resolution. , 1981, Journal of molecular biology.

[15]  G. Massiot,et al.  Pharmacognosie: Phytochimie, Plantes Médicinales: : By J. Bruneton, 2nd Edn, Tec Doc, Paris, 1993. 928pp. 78OF ISBN 2-85206-911-3. , 1994 .

[16]  M. Sundaralingam,et al.  Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol,. , 1997, Biochemistry.

[17]  I. Posadas,et al.  Cavernolide: a new inhibitor of human sPLA2 sharing unusual chemical features. , 2000, Life sciences.

[18]  Philippe Bernard,et al.  Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment , 1999, J. Comput. Aided Mol. Des..

[19]  R. Mayer,et al.  New insights on mammalian phospholipase A2(s); comparison of arachidonoyl‐selective and ‐nonselective enzymes , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Y. Hannun,et al.  Role of phospholipases in generating lipid second messengers in signal transduction 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.